These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3120453)

  • 1. Purification of human factor VIII from a heat-treated factor VIII concentrate in the presence of potent protease inhibitors.
    Shima M; Yoshioka A; Tanaka I; Fujiwara T; Nakai H; Tsubura Y; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1987 Sep; 50(6):1239-45. PubMed ID: 3120453
    [No Abstract]   [Full Text] [Related]  

  • 2. [Production of factor VIII deficient plasma by immunodepletion using monoclonal antibodies to vWF and to factor VIII, and its application].
    Nakai H; Shima M; Tanaka I; Fujiwara T; Terada S; Takase T; Yoshioka A; Fukui H
    Rinsho Byori; 1988 Apr; 36(4):475-80. PubMed ID: 3136264
    [No Abstract]   [Full Text] [Related]  

  • 3. Human factor VIII:C purified using monoclonal antibody to von Willebrand factor.
    Levine PH
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):1-2. PubMed ID: 3133770
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
    Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
    Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical properties of Monoclate factor VIII:C antihemophilic factor (human) using monoclonal antibody to von Willebrand factor (VWF).
    Nilsson IM
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):33-7. PubMed ID: 3133776
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoclonal antibodies against human factor VIII and von Willebrand factor].
    Yoshioma A; Shima M
    Nihon Ketsueki Gakkai Zasshi; 1987 May; 50(3):681-7. PubMed ID: 3122486
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor VIII/von Willebrand factor.
    Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1510-8. PubMed ID: 2451878
    [No Abstract]   [Full Text] [Related]  

  • 8. Registry of monoclonal antibodies to factor VIII and von Willebrand factor. International Committee on Thrombosis and Haemostasis.
    Goodall AH; Meyer D
    Thromb Haemost; 1985 Dec; 54(4):878-91. PubMed ID: 3937279
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patients.
    Avner P; Arnaud D; Sultan Y; Maisonneuve P; Jeanneau C
    Dev Biol Stand; 1984; 57():69-76. PubMed ID: 6084622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope localization of monoclonal antibodies against factor VIII light chain which inhibit complex formation by factor VIII with von Willebrand factor.
    Shima M; Yoshioka A; Nakai H; Tanaka I; Sawamoto Y; Kamisue S; Terada S; Fukui H
    Int J Hematol; 1991 Dec; 54(6):515-22. PubMed ID: 1724391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoaffinity purification of factor VIII complex.
    Hornsey VS; Griffin BD; Pepper DS; Micklem LR; Prowse CV
    Thromb Haemost; 1987 Feb; 57(1):102-5. PubMed ID: 3109055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Factor VIII:C purified using monoclonal antibody to von Willebrand factor. Proceedings from a satellite symposium, XIth International Congress on Thrombosis and Haemostasis. July 11, 1987, Brussels.
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):1-45. PubMed ID: 3133771
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification of factor VIII by monoclonal antibody affinity chromatography.
    Zimmerman TS
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):25-6. PubMed ID: 3133773
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of protease inhibition in studies on purified factor VIII (antihaemophilic factor).
    Beck EA; Bachmann P; Barbier P; Furlan M
    Thromb Haemost; 1976 Feb; 35(1):186-90. PubMed ID: 1085500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand disease.
    Morfini M; Mannucci PM; Tenconi PM; Longo G; Mazzucconi MG; Rodeghiero F; Ciavarella N; De Rosa V; Arter A
    Thromb Haemost; 1993 Aug; 70(2):270-2. PubMed ID: 8236134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
    Ikematsu S; Yorifuji H; Arai M; Fukutake K
    Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoaffinity purification of factor VIII.
    Weinstein RE
    Ann Clin Lab Sci; 1989; 19(2):84-91. PubMed ID: 2502062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].
    Batlle J; Blanco-López MJ; Castiñeira MP; López-Fernández MF
    Sangre (Barc); 1992 Jun; 37(3):211-24. PubMed ID: 1359656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies].
    Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Miyata S; Sawamoto Y; Kamisue S; Fukui H
    Rinsho Ketsueki; 1989 Jul; 30(7):951-7. PubMed ID: 2509762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.